Nurse’s Drug Handbook 17+
Skyscape Medpresso Inc
-
- 免費
- 提供 App 內購買項目
螢幕截圖
描述
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
The Jones & Bartlett Learning Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a no-nonsense style that speaks your language in terms you use every day, it offers concise and consistently formatted drug entries organized alphabetically.
It will help you provide safe, effective drug therapy because of its practical, easy-to-understand, accurate, and reliable information on virtually all the drugs you’re likely to administer.
Key Features:
* Index of all generic, trade, and alternate drug names
* Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule
* Indications and dosages, as well as route, onset, peak, and duration information
* Incompatibilities and contraindications
* Interactions with drugs, food, and activities
* Adverse reactions
* Nursing considerations, including key teaching points for patients
* Mechanism-of-action illustrations
* Warnings and precautions
* Updated antineoplastic drug therapy appendix
* Addition of bolded Life-Threatening Adverse Reactions (ADRs)
* NEW TO THIS EDITION
* New drugs added to the Nurse's Drug Handbook include: PEGlated-auci jivi, baloxavir marboxil, baricitinib, inactivated-zhzo, didanosine, doravirine, Eravacycline, erenumab-aooe, fremanezumab-vfrm, frovatriptan, galcanezumab-gnlm, ganiciclovir, ibalizumab-uiyk, lofexidine, lubiprostone, omadacycline, plazomicin, revefenacin, rifamycin, saquinavir, sarecycline, semaglutide, sodium zirconium cyclosilicate, sufentanil, tildrakizumab-asmn
* New drug facts on hundreds of existing entries, including updated information on new indications and dosages, new incompatibilities and interactions, new adverse reactions, and new nursing considerations.
* Hundreds of patient-teaching guidelines and suggestions.
* Thoroughly updated appendices on insulin preparations, oral allergen extracts, antiviral drugs, topical drugs, antihistamines, combination antihypertensive drugs, interferons, ophthalmic drugs, and antineoplastic drugs, as well as selected obstetrical drugs and vitamins.
ISBN 10: 1284167909
ISBN 13: 978-1284167900
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $26.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable."
If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
https://www.skyscape.com/index/privacy.aspx
訂閱項目
App 私隱
開發者表明Skyscape Medpresso Inc的私隱慣例或包括下列資料的處理。詳情請參閱開發者的私隱政策。
不會與你連結的資料
開發者可能會收集以下資料,但不會連結你的個人身份:
- 用户內容
- 搜尋記錄
- 識別碼
- 使用資料
- 診斷
私隱慣例或因使用的功能或年齡等因素而異。進一步了解
資料
- 供應商
- Skyscape Medpresso Inc
- 大小
- 12.2 MB
- 類別
- 醫藥
- 兼容性
-
- iPhone
- 須使用 iOS 12.0 或以上版本。
- iPad
- 須使用 iPadOS 12.0 或以上版本。
- iPod touch
- 須使用 iOS 12.0 或以上版本。
- Mac
- 須使用 macOS 10.15 或以上版本。
- Apple Vision
- 須使用 visionOS 1.0 或以上版本。
- 語言
-
英文
- 年齡
- 17+ 頻繁/極度的藥物或治療資訊 偶爾/輕度使用或提及酒精、煙草或藥物
- Copyright
- © (c) 1998-2022 Skyscape Medpresso, Inc. All rights reserved.
- 價格
- 免費
- App 內購買項目
-
- Nurse's Drug Handbook 1/Y Sub HK$ 208.00
- 25% Off - Limited Time Offer HK$ 168.00
- 20% Off - Limited Time Offer HK$ 188.00
- 15% Off - Limited Time Offer HK$ 188.00
- Nurse's Drug HBK 1/Y Sub Offer HK$ 173.00